FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372492009: Phenylbutylpiperadine derivative antipsychotic agent (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1197785012 Phenylbutylpiperadine derivative antipsychotic agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211027011 Phenylbutylpiperadine derivative antipsychotic agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1197785012 Phenylbutylpiperadine derivative antipsychotic agent (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1197785012 Phenylbutylpiperadine derivative antipsychotic agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211027011 Phenylbutylpiperadine derivative antipsychotic agent en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1211027011 Phenylbutylpiperadine derivative antipsychotic agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Phenylbutylpiperadine derivative antipsychotic agent Is a Anti-psychotic agent (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing haloperidol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Phenylbutylpiperadine derivative antipsychotic agent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol [antipsychotic] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol 1.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely haloperidol 5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol 20 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely haloperidol 2 milligram/1 milliliter conventional release oral solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol 2mg/5mL s/f oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol 1mg/5mL s/f oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely haloperidol 500 microgram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol 1 mg/mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol 20mg/2mL injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol 1.5mg/5mL s/f oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    décanoate d'halopéridol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol [tics, chorea] [see D47..] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing haloperidol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing haloperidol in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol decanoate 50mg/mL injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol 0.5mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol 100mg injection solution ampoule (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol 5mg injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Oral haloperidol solution (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol 500 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Haloperidol (substance) Is a False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)
    Trifluperidol (substance) Is a False Phenylbutylpiperadine derivative antipsychotic agent Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start